Diagnosis and management of organic ovarian cysts: Indications and procedures for laparoscopy

Human Reproduction Update

Volumn 2, Issue 5, 1996, Pages 435-446

  Chapron, Charles ^a   Dubuisson, Jean Bernard ^a   Fritel, Xavier ^a   Rambaud, Didier ^a  

^a Université Paris Descartes   (France)

Author keywords

Diagnosis laparoscopy; Endoscopic bag; Operative laparoscopy; Organic ovarian cyst; Ovarian cancer

Indexed keywords

TUMOR MARKER;

ARTICLE; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; FEMALE INFERTILITY; GYNECOLOGIC SURGERY; HUMAN; LAPAROSCOPIC SURGERY; LAPAROTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; OVARY CYST; PERITONEAL DISEASE; PRIORITY JOURNAL; RISK; SURGICAL TECHNIQUE;

CA-125 ANTIGEN; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; LAPAROSCOPY; MAGNETIC RESONANCE IMAGING; NEOPLASM SEEDING; OVARIAN CYSTS; OVARIAN NEOPLASMS; ULTRASONOGRAPHY, DOPPLER;

EID: 0030469519     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/2.5.435     Document Type: Article

References (95)

1. Alexander, R.J.T., Jacques, B.C. and Mitchell, K.G. (1993) Laparoscopically assisted colectomy and wound recurrence. Lancet, 341, 249-250.
2. Barnhill, D.R., Hoskins, W.J., Heller, P.B. and Park, R.C. (1984) The second-look surgical reassessment for epithelial ovarian carcinoma. Gynecol. Oncol., 19, 148-154.
3. Bast, R.C., Feefney, M., Lazarus, H. et al. (1981) Reactivity of a monoclonal antibody with human ovarian carcinoma. J. Clin. Invest., 68, 1331-1337.
4. Bell, D.A. and Scully, R.E. (1994) Early de novo ovarian carcinoma. Cancer, 73, 1859-1864.
5. Benacerraf, B.R., Finkler, N.J., Wojciechowski, C. and Knapp, R.C. (1990) Sonographic accuracy in the diagnosis of ovarian masses. J. Reprod. Med., 35, 490-495.
6. Benifla, J.L., Hauuy, J.P., Guglielmina, J.N. et al. (1992) Kystectomie percoelioscopique: decouverte histologique fortuite d'un carcinome ovarien. J. Gynecol. Obstet. Biol. Reprod., 21, 45-49.
7. Blanc, B., Nicoloso, E., d'Ercole, C. et al. (1993) Danger du traitement coelioscopique systematique de la pathologie ovarienne. Presse Med., 22, 1732-1734.
8. Bostwick, D.G., Tazelaar, H.D., Ballon, S.C. et al. (1986) Ovarian tumors of borderline malignancy, a clinical and pathologic study of 109 cases. Cancer, 58, 2052-2065.
9. Bourne, T., Campbell, S., Steer, C. et al. (1989) Transvaginal colour flow imaging: a possible new screening technique for ovarian cancer. Br. Med. J., 299, 1367-1370.
10. Brioschi, P.A., Irion, O., Bischof, P. et al. (1987) Serum CA 125 in epithelial ovarian cancer. Br. J. Obstet. Gynaecol., 94, 196-201.
11. Bulletti, C., Seracchioli, R., Polli, V. et al. (1996) Financial impact in the Italian Health Service of laparoscopic versus laparotomic surgery for the treatment of ovarian cysts. Hum. Reprod., 11, 287-290.
12. Buy, J.N., Ghossain, M.A., Sciot, C. et al. (1991) Epithelial tumors of the ovary: CT findings and correlation with US. Radiology, 178, 811-818.
13. Canis, M., Mage, G., Pouly, J.L. et al. (1994a) Laparoscopic diagnosis of adnexal cystic masses: a 12-year experience with long-term follow-up. Obstet. Gynecol., 83, 707-712.
14. Canis, M., Mage, G., Wattiez, A. et al. (1994b) Tumor dissemination following laparoscopic excision of an ovarian cancer (Stage IA): case report. In Bruhat, M.A. (ed.), The Management of Adnexal Cysts. Blackwell Scientific Publications, Oxford, UK, pp. 109-113.
15. Cariker, M. and Dockerty, M. (1954) Mucinous cystademomas and mucinous cystadenocarcinoma of the ovary. A clinical and pathological study of 355 cases. Cancer, 7, 302-310.
16. Chambers, J.T. (1989) Borderline ovarian tumors: a review of treatment. Yale J. Biol. Med., 62, 351-365.
17. Chapron, C. and Dubuisson, J.B. (1996) Laparoscopic treatment of ovarian dermoid cysts. Am. J. Obstet. Gynecol., 175, 234-235.
18. Chapron, C. and Querleu, D. (1994) Complications de l'Endoscopie Operatoire en Gynecologie. Arnette, Paris, France.
19. Chapron, C., Dubuisson, J.B., Fritel, X. et al. (1994a) Techniques et indications de l'utilisation du sac endoscopique dans la prise en charge des kystes ovariens. Contracept. Fertil. Sex., 22, 682-684.
20. Chapron, C., Dubuisson, J.B., Samouh, N. et al. (1994b) Treatment of ovarian dermoid cysts. Place and modalities of operative laparoscopy. Surg. Endosc., 8, 1092-1095.
21. Chen, D., Schwartz, P.E., Li, X. and Yang, Z. (1988) Evaluation of CA 125 levels in differentiating malignant from benign tumors in patients with pelvic masses. Obstet. Gynecol., 72, 23-27.
22. Childers, J.M., Aqua, K.A., Surwit, E.A. et al. (1994) Abdominal-wall tumor implantation after laparoscopy for malignant conditions. Obstet. Gynecol., 84, 765-769.
23. Corfman, R.S., Diamond, M.P. and De Cherney, A.H. (1993) Complications of Laparoscopy and Hysteroscopy. Blackwell Scientific Publications, Oxford, UK.
24. Cox, D.R. (1972) Regression models and life tables (with discussion). J. R. Stat. Soc., 34, 187-202.
25. Cristalli, B., Cayol, A., Izard, V. and Levardon, M. (1992) Benefit of operative laparoscopy for ovarian tumors suspected of benignity. J. Laparoendosc. Surg., 2, 69-73.
26. Crouet, H. and Heron, J.F. (1991) Dissemination du cancer de l'ovaire lors de la chirurgie coelioscopique: un danger reel. Presse Med., 20, 1738.
27. Cruickshank, D.J., Fullerton, W.T. and Klopper, A. (1987) The clinical signifiance of pre-operative serum CA 125 in ovarian cancer. Br. J. Obstet. Gynaecol., 94, 692-695.
28. Dembo, A.J., Davy, M., Stenwig, A.E. et al. (1990) Prognostic factors in patients with stage I epithelial ovarian cancer. Obstet. Gynecol., 75, 263-273.
29. Diddle, A.W. (1949) End results in the surgical treatment of ovarian cancer. Am. J. Obstet. Gynecol., 58, 790-794.
30. Drouard, F., Delamarre, J. and Capron, J.P. (1991) Cutaneous seeding of gallbladder cancer after laparoscopic cholecystectomy. N. Engl. J. Med., 325, 1316.
31. Dubuisson, J.B., Meneux, E., Chapron, C. et al. (1992) Technique de la coeliochirurgie dans le traitements des kystes de l'ovaire. Contracept. Fertil. Sex., 20, 547-551.
32. Einhorn, N. (1992) Ovarian cancer, early diagnosis and screening. North Am. Clin. Hematol. Oncol., 6, 843-850.
33. Erdmann, J.F. and Spaulding, H.V. (1921) Papillary cystadenoma of the ovary. Surg. Gynecol. Obstet., 33, 362-375.
34. Finkler, N.J., Benaceraff, B., Lavin, P.T. et al. (1988) Comparison of serum CA 125, clinical impression, and ultrasound in the preoperative evaluation of ovarian masses. Obstet. Gynecol., 72, 659-664.
35. Finn, C.B., Luesley, D.M., Buxton, E.J. et al. (1992) Is stage I epithelial ovarian cancer overtreated both surgically and systemically? Results of a five-year cancer registry review. Br. J. Obstet. Gynaecol., 99, 54-58.
36. Fisken, J., Roulston, J.E., Sturgeon, C. et al. (1993) The value of the human milk fat globule membrane antigen HMFG2 in epithelial ovarian cancer monitoring: comparison with CA125. Br. J. Cancer, 67, 1065-1070.
37. Fleischer, A.C., Rodgers, W.H., Rao, B.K. et al. (1991) Assessment of ovarian tumor vascularity with transvaginal color Doppler sonography. J. Ultrasound Med., 10, 563-568.
38. Forest, A.M., Bremond, A., Leveque, J. and Viallet, A. (1990) Kyste de l'ovaire: place respective de l'examen clinique, de l'echographie, des marqueurs biologiques, et de la cytologie. J. Gynecol. Obstet. Biol. Reprod., 19, 829-836.
39. Gadducci, A., Ferdeghini, M., Prontera, C. et al. (1992) The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis. Gynecol. Oncol., 44, 147-154.
40. Gleeson, N.C., Nicosia, S.V., Mark, J.E. et al. (1993) Abdominal wall metastases from ovarian cancer after laparoscopy. Am. J. Obstet. Gynecol., 169, 522-523.
41. Gore, M.E., Cooke, J.C., Wiltshaw, E. et al. (1989) The impact of computed tomography and ultrasonography on the management of patients with carcinoma of the ovary. Br. J. Cancer, 60, 751-754.
42. Granberg, S., Norstrom, A. and Wikland, M. (1991) Comparison of endovaginal ultrasound and cytological evaluation of cystic ovarian tumors. J. Ultrasound Med., 10, 9-14.
43. Halme, J.K. (1994) Reasons for laparoscopic management of persistent ovarian masses. In Hulka, J.F. and Reich, H. (eds), Textbook of Laparoscopy. 2nd edition, W.B. Saunders Company, Philadelphia, PA, USA, pp. 253-255.
44. Hata, K., Hata, T., Manabe, A., Sugimura, K. and Kitao, M. (1992) A critical evaluation of transvaginal Doppler studies, transvaginal sonography, magnetic resonance imaging, and CA 125 in detecting ovarian cancer. Obstet. Gynecol., 80, 922-926.
45. Helewa, M.E., Krepart, G.V. and Lotocki, R. (1986) Staging laparotomy in early epithelial ovarian carcinoma. Am. J. Obstet. Gynecol., 154, 282-286.
46. Herrmann, U.J., Locher, G.W. and Goldhirsch, A. (1987) Sonographic patterns of ovarian tumors: prediction of malignancy. Obstet. Gynecol., 69, 777-781.
47. Hopkins, M.P. and Morley, G.W. (1989) The second-look operation and surgical reexploration in ovarian tumor of low malignant potential. Obstet. Gynecol., 74, 375-378.
48. Hsiu, J.G., Given, F.T. and Kemp, G.M. (1986) Tumor implantation after diagnostic laparoscopic biopsy of serous ovarian tumors of low malignant potential. Obstet. Gynecol., 68, 90S-93S.
49. Hulka, J.F., Parker, W.H., Surrey, M.W. and Phillips, J.M. (1992) Management of ovarian masses, AAGL 1990 survey. J. Reprod. Med., 37, 599-602.
50. Inoue, M., Fujita, M., Nakazawa, A. et al. (1992) Ca 19-9, CA 125 carcinoembryonic antigen, and tissue polypeptide antigen in differentiating ovarian cancer from benign tumors. Obstet. Gynecol., 79, 434-440.
51. International Federation of Gynecology and Obstetrics (1987) Changes in definitions of clinical staging for carcinoma of the cervix and ovary. Am. J. Obstet. Gynecol., 156, 263-264.
52. Jacobs, I., Oram, D., Fairbanks, J. et al. (1990) A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br. J. Obstet. Gynaecol., 97, 922-929.
53. Kawai, M., Kikkawa, F., Ishikawa, H. et al. (1994) Differential diagnosis of ovarian tumors by transvaginal color-pulse Doppler sonography. Gynecol. Oncol., 54, 209-214.
54. Keckstein, J., Ulrich, U., Sasse, V. et al. (1996) Reduction of postoperative adhesion formation after laparoscopic ovarian cystectomy. Hum. Reprod., 11, 579-582.
55. Kurjak, A., Schulman, H., Sosic, A. et al. (1992) Transvaginal ultrasound, color flow, and Doppler waveform of the postmenopausal adnexal mass. Obstet. Gynecol., 80, 917-921.
56. Kurjak, A., Predanic, M., Kupesic-Urek, S. and Jukic, S. (1993) Transvaginal color and pulsed Doppler assessment of adnexal tumor vascularity. Gynecol. Oncol., 50, 3-9.
57. Lacey, C.G., Morrow, C.P., Disaia, P.J. and Lucas, W.E. (1978) Laparoscopy in the evaluation of gynecologic cancer. Obstet. Gynecol., 52, 708-712.
58. Leake, J.F., Currie, J.L., Rosenshein, N.B. and Woodruff, J.D. (1992) Long-term follow-up of serous ovarian tumors of low malignant potential. Gynecol. Oncol., 47, 150-158.
59. Luxman, O., Bergman, A., Sagi, J. and David, B.P. (1991) The postmenopausal adnexal mass: correlation between ultrasonic and pathologic findings. Obstet. Gynecol., 77, 726-728.
60. Maiman, M., Seltzer, V. and Boyce, J. (1991) Laparoscopic excision of ovarian neoplasm subsequently found to be malignant. Obstet. Gynecol., 77, 563-565.
61. Malkasian, G.D., Knapp, R.C., Lavin, P.T. et al. (1988) Preoperative evaluation of CA125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease. Am. J. Obstet. Gynecol., 159, 341-346.
62. Malloy, J.J., Dockerty, M.B., Welch, J.S. and Hunt, A.B. (1965) Papillary ovarian tumors. I. Benign tumors and serous and mucinous cystadenocarcinomas. Am. J. Obstet. Gynecol., 93, 867-879.
63. Manchul, L.A., Simm, J., Lewin, W. et al. (1992) Borderline epithelial ovarian tumors: a review of 81 cases with an assessment of the impact of treatment. Int. J. Rad. Oncol. Biol. Phys., 22, 867-874.
64. Mann, W.J., Pastner, B., Cohen, H. and Loesch, M. (1988) Preoperative serum CA 125 levels in patients with surgical stage I invasive ovarian adenocarcinoma. J. Natl. Cancer Inst., 80, 208-209.
65. Meigs, J.V. (1940) Cancer of the ovary. Surg. Gynecol. Obstet., 71, 44-53.
66. Mettler, L., Caesar, G., Neunzling, S. and Semm, K. (1993) Stellenwert der endoskopischen Ovar-Chirurgie, Kritische Analyse von 626 pelviskopish operierten Ovarialzysten an der Universitats-Frauenklinik Kiel 1990-1991. Geburtshilfe Frauenheilkd., 53, 253-257.
67. Molina, R., Ojeda, B., Filella, X. et al. (1992) A prospective study of tumor markers CA 125 and CA 19.9 in patients with epithelial ovarian carcinomas. Tumor Biol., 13, 278-286.
68. Nargund, G., Cheng, W.C. and Parsons, J. (1996) The impact of ovarian cystectomy on ovarian reponse to stimulation during in-vitro fertilization cycles. Hum. Reprod., 11, 81-83.
69. Nezhat, F., Nezhat, C., Welander, C.E. and Benigno, B. (1992) Four ovarian cancers diagnosed during laparoscopic management of 1011 women with adnexal masses. Am. J. Obstet. Gynecol., 167, 790-796.
70. O'Connell, G.J., Ryan, E., Murphy, J. and Prefontaine, M. (1987) Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses. Obstet. Gynecol., 70, 930-932.
71. Parker, R.T., Parker, C.H. and Wibanks, G.D. (1970) Cancer of the ovary. Survival studies based upon operative therapy, chemotherapy and radiotherapy. Am. J. Obstet. Gynecol., 108, 878-888.
72. Pastner, B. (1990) Preoperative serum CA-125 levels in early stage ovarian cancer. Eur. J. Gynaecol. Oncol., 13, 319-321.
73. Pastner, B. and Mann, W.J. (1988) The value of preoperative serum CA125 levels in patients with a pelvic mass. Am. J. Obstet. Gynecol., 159, 873-876.
74. Purula, E. and Nieminen, U. (1968) Does rupture of cystic carcinoma during operation influence prognosis? Ann. Chir. Gynaecol. Fenn., 57, 615-617.
75. Querleu, D. (1993) Laparoscopic paraaortic node sampling in gynecologic oncology: a preliminary experience. Gynecol. Oncol., 49, 24-29.
76. Sainz de la Cuesta, R., Goff, B., Fuller, A.F., Jr et al. (1994) Prognostic importance of intraoperative rupture of malignant ovarian epithelial neoplasm. Obstet. Gynecol., 84, 1-7.
77. Sanders, R.C., Mc Neil, B.J., Finberg, H.J. et al. (1983) A prospective study of computed tomography and ultrasound in the detection and staging of pelvic masses. Radiology, 146, 439-442.
78. Sassone, A.M., Timor-Tritsch, I.E., Artner, A. et al. (1991) Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy. Obstet. Gynecol., 78, 70-76.
79. Sevelda, P., Dittrich, C. and Salzer, H. (1989) Prognostic value of the rupture of the capsule in Stage I epithelial ovarian carcinoma. Gynecol. Oncol., 35, 321-322.
80. Sevelda, P., Vavra, N., Schemper, M. and Salzer, H. (1990) Prognostic factors for survival in stage I epithelial ovarian carcinoma. Cancer, 65, 2349-2352.
81. Soper, J.T., Johnson, P., Johnson, V. et al. (1992) Comprehensive restaging laparotomy in women with apparent early ovarian carcinoma. Obstet. Gynecol., 80, 949-953.
82. Spinelli, P., Luini, A., Pizzetti, P. and De Palo, G.M. (1976) Laparoscopy in staging and restaging of 95 patients with ovarian carcinoma. Tumori, 62, 493-502.
83. Tasker, M. and Langley, F.A. (1985) The outlook for women with borderline epithelial tumours of the ovary. Br. J. Obstet. Gynaecol., 92, 969-973.
84. Timor-Trisch, I.E., Lerner, J.P., Monteagudo, A. and Santos, R. (1993) Transvaginal ultrasonographic characterization of ovarian masses by means of color flow-directed Doppler measurements and a morphologic scoring system. Am. J. Obstet. Gynecol., 168, 909-913.
85. Tissot, E., Naouri, A., Naouri, C. and Ennassih, A. (1994) Metastase ovarienne d'un cancer du pancreas meconnu au cours d'un traitement coelioscopique. Presse Med., 23, 494.
86. Trimbos, J.B. and Hacker, N.F. (1993) The case against aspirating ovarian cyst. Cancer, 72, 828-831.
87. Turner, J.C., Remine, W.H. and Dockerty, M.B. (1959) A clinicopathologic study of 172 patients with primary carcinoma of the ovary. Surg. Gynecol. Obstet., 109, 198-206.
88. Valentin, L., Sladkevicius, P. and Marsal, K. (1994) Limited contribution of Doppler velocimetry to the differential diagnosis of extrauterine pelvic tumors. Obstet. Gynecol., 83, 425-433.
89. Vasilev, S.A., Schlaerth, J.B., Campeau, J. and Morrow, C.P. (1988) Serum CA 125 levels in preoperative evaluation of pelvic masses. Obstet. Gynecol., 71, 751-756.
90. Vercellini, P., Oldani, S., Felicetta, I. et al. (1995) The value of cyst puncture in the differential diagnosis of benign ovarian tumours. Hum. Reprod., 10, 1465-1469.
91. Webb, M.J., Decker, D.G., Mussey, E. and Williams, T.J. (1973) Factors influencing survival in stage I ovarian cancer. Am. J. Obstet. Gynecol., 116, 222-228.
92. Weiner, Z., Thaler, I., Beck, D. et al. (1992) Differentiating malignant from benign ovarian tumors with transvaginal color flow imaging. Obstet. Gynecol., 79, 159-162.
93. Williams, T.J., Symmonds, R.E. and Litwak, O. (1973) Management of unilateral and encapsulated ovarian cancer in young women. Gynecol. Oncol., 1, 143-148.
94. Wu, C.C., Lee, C.N., Chen, T.M. et al. (1994) Incremental angiogenesis assessed by color Doppler ultrasound in the tumorigenesis of ovarian neoplasms. Cancer, 73, 1251-1256.
95. Zurawski, V.R., Knapp, R.C., Einhorn, N. et al. (1988) An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma. Gynecol. Oncol., 30, 7-14.